7OZY
FGFR2 kinase domain (residues 461-763) in complex with 38.
This is a non-PDB format compatible entry.
Summary for 7OZY
Entry DOI | 10.2210/pdb7ozy/pdb |
Descriptor | Fibroblast growth factor receptor 2, 4-[3-(4-piperazin-4-ium-1-ylphenyl)-1H-indazol-6-yl]phenol, SULFATE ION, ... (5 entities in total) |
Functional Keywords | fgfr2, inhibitor, receptor tyrosine kinase, transferase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 70605.53 |
Authors | Trinh, C.H.,Turner, L.D.,Fishwick, C.W.G. (deposition date: 2021-06-29, release date: 2021-12-01, Last modification date: 2024-01-31) |
Primary citation | Turner, L.D.,Trinh, C.H.,Hubball, R.A.,Orritt, K.M.,Lin, C.C.,Burns, J.E.,Knowles, M.A.,Fishwick, C.W.G. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. J.Med.Chem., 65:1481-1504, 2022 Cited by PubMed: 34780700DOI: 10.1021/acs.jmedchem.1c01163 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.28 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)